Alison J. Yarnall

8.7k citations

111 papers · 5.5k indexed · 2 hit papers · h-index 40

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments 79
- Neurological disorders and treatments 29
- Botulinum Toxin and Related Neurological Disorders 9
Physical Therapy, Sports Therapy and Rehabilitation top 0.5%
- Balance, Gait, and Falls Prevention 24
Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 79
- Neurological disorders and treatments 29
- Botulinum Toxin and Related Neurological Disorders 9
Psychiatry and Mental health top 1%
- Cerebral Palsy and Movement Disorders 19
- Dementia and Cognitive Impairment Research 16
Geriatrics and Gerontology top 2%
Complementary and alternative medicine
- Ginkgo biloba and Cashew Applications 14
Cellular and Molecular Neuroscience
- Genetic Neurodegenerative Diseases 6

Co-authors: David J. Burn Gordon W. Duncan Tien K. Khoo Lynn Rochester Roger A. Barker Rachael A. Lawson John T. O’Brien David J. Brooks
Cited by: Neurology Physical Therapy, Sports Therapy and Rehabilitation
Partner nations: United Kingdom Australia United States

In The Last Decade

Alison J. Yarnall

103 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches
2013 Characterizing mild cognitive impairment in incident Parkinson disease

Peers

Countries citing papers authored by Alison J. Yarnall

Since Specialization

Citations

This map shows the geographic impact of Alison J. Yarnall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. Yarnall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. Yarnall more than expected).

Fields of papers citing papers by Alison J. Yarnall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. Yarnall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. Yarnall. The network helps show where Alison J. Yarnall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alison J. Yarnall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison J. Yarnall Line = papers co-authored together Alison J. Yarnall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson’s disease: a double-blind, randomised sham-controlled proof-of-concept study Hilmar P. Sigurdsson,Heather L. Hunter,Lisa Alcock,Evangeline E. Maughan,Harvey Bramley,Philip Brown,Giovanni Palermo,Mark R. Baker,John‐Paul Taylor,Lynn Rochester,Alison J. Yarnall	2025	0
2	Self-supervised learning of wrist-worn daily living accelerometer data improves the automated detection of gait in older adults Yonatan E. Brand,Felix Kluge,Luca Palmerini,Anisoara Paraschiv-Ionescu,Clemens Becker,Andrea Cereatti,Walter Maetzler,Basil Sharrack,Beatrix Vereijken,Alison J. Yarnall,Lynn Rochester,Silvia Del Din,Arne Müller,Aron S. Buchman,Jeffrey M. Hausdorff,Or Perlman	2024	5
3	Delirium is more common and associated with worse outcomes in Parkinson’s disease compared to older adult controls: results of two prospective longitudinal cohort studies Florence Gerakios,Alison J. Yarnall,Gemma Bate,Laura Wright,Daniel Davis,Blossom C. M. Stephan,Louise Robinson,Carol Brayne,Glenn T. Stebbins,John‐Paul Taylor,David J. Burn,Louise Allan,Sarah Richardson,Rachael A. Lawson	2024	8
4	Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression B Whittle,Osagie Izuogu,Hannah Lowes,Dasha Deen,Angela Pyle,Jon Coxhead,Rachael A. Lawson,Alison J. Yarnall,Michael S. Jackson,Mauro Santibanez‐Koref,Gavin Hudson	2024	11
5	Living with pain and Parkinson’s developing an understanding of the impact, trajectory and pain management needs: a qualitative interview study protocol Jenni Naisby,Leah Avery,Katherine Baker,Mark Parkinson,Annette Hand,Lynn Rochester,Alison J. Yarnall,Richard Walker,Darren Flynn,Cormac Ryan,Tracy Finch	2024	0
6	Feasibility and usability of a digital health technology system to monitor mobility and assess medication adherence in mild-to-moderate Parkinson's disease Héloïse Debelle,Emma Packer,Esther Beales,Harry G. B. Bailey,Ríona Mc Ardle,Philip M. Brown,Heather L. Hunter,Fabio Ciravegna,Neil Ireson,Jordi Evers,Martijn Niessen,Jian Shi,Alison J. Yarnall,Lynn Rochester,Lisa Alcock,Silvia Del Din	2023	22
7	The prevalence of sarcopenia in Parkinson’s disease and related disorders- a systematic review Ashley Hart,Laura Cordova‐Rivera,Fred Barker,Avan Aihie Sayer,Antoneta Granic,Alison J. Yarnall	2023	14
8	Documentation and diagnosis of delirium in Parkinson's disease Rachel J. Cullinan,Sarah Richardson,Alison J. Yarnall,David J. Burn,Louise Allan,Rachael Lawson	2022	6
9	Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease Nicola J. Ray,Rachael Lawson,Sarah L. Martin,Hilmar P. Sigurdsson,Joanna Wilson,Brook Galna,Sue Lord,Lisa Alcock,Gordon W. Duncan,Tien K. Khoo,John T. O’Brien,David J. Burn,John‐Paul Taylor,River C. Rea,Maurizio Bergamino,Lynn Rochester,Alison J. Yarnall	2022	23
10	Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease Hilmar P. Sigurdsson,Alison J. Yarnall,Brook Galna,Sue Lord,Lisa Alcock,Rachael A. Lawson,Sean J. Colloby,Michael Firbank,John‐Paul Taylor,Nicola Pavese,David J. Brooks,John T. O’Brien,David J. Burn,Lynn Rochester	2022	11
11	Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesbreakdown → Nicolaas I. Bohnen,Alison J. Yarnall,Rimona S. Weil,Elena Moro,Mark S. Moehle,Per Borghammer,Marc‐André Bédard,Roger L. Albin	2022	145
12	Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospects Hilmar P. Sigurdsson,Rachael K. Raw,Heather L. Hunter,Mark R. Baker,John‐Paul Taylor,Lynn Rochester,Alison J. Yarnall	2021	27
13	Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson’s Disease in the ICICLE-PD Cohort Rachael A. Lawson,(unknown),Caroline H. Williams‐Gray,Marta Camacho,Gordon W. Duncan,Tien K. Khoo,David P. Breen,Roger A. Barker,Lynn Rochester,David J. Burn,Alison J. Yarnall	2021	21
14	Sarcopenia and frailty in individuals with dementia: A systematic review Samantha J. Waite,Stuart Maitland,Alan Thomas,Alison J. Yarnall	2020	83
15	Frailty status predicts falls in early Parkinson’s disease [abstract] Steven M. Holland,Rosie Morris,Brook Galna,Lynn Rochester,Alison J. Yarnall	2019	1
16	Postural Dynamics Are Associated With Cognitive Decline in Parkinson's Disease Annette Pantall,Piriya Suresparan,Leanne Kapa,Rosie Morris,Alison J. Yarnall,Silvia Del Din,Lynn Rochester	2018	23
17	The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease Isobel Sleeman,Terry Aspray,Rachael A. Lawson,Shirley Coleman,Gordon W. Duncan,Tien K. Khoo,Inez Schoenmakers,Lynn Rochester,David J. Burn,Alison J. Yarnall	2017	58
18	Quality of Life and Mild Cognitive Impairment in Early Parkinson’s Disease: Does Subtype Matter? Rachael A. Lawson,Alison J. Yarnall,Gordon W. Duncan,Tien K. Khoo,David P. Breen,Roger A. Barker,Daniel Collerton,John‐Paul Taylor,David J. Burn	2015	25
19	Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease Sophia Carbutt,Jennifer Duff,Alison J. Yarnall,David J. Burn,Gavin Hudson	2015	10
20	Cholinergic deficits contribute to impaired postural control in early Parkinson's disease Alison J. Yarnall,Silvia Del Din,R David,Brook Galna,Mark R. Baker,David J. Burn,Lynn Rochester	2014	1

About Alison J. Yarnall

Alison J. Yarnall is a scholar working on Neurology, Physical Therapy, Sports Therapy and Rehabilitation and Psychiatry and Mental health, having authored 111 papers that have together received 5.5k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (79 papers), Neurological disorders and treatments (29 papers), Balance, Gait, and Falls Prevention (24 papers), Cerebral Palsy and Movement Disorders (19 papers), Dementia and Cognitive Impairment Research (16 papers), Ginkgo biloba and Cashew Applications (14 papers), Botulinum Toxin and Related Neurological Disorders (9 papers) and Genetic Neurodegenerative Diseases (6 papers). The work is most often cited by research in Neurology (3.6k citations), Physical Therapy, Sports Therapy and Rehabilitation (744 citations) and Neurology (612 citations). Alison J. Yarnall has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include David J. Burn, Gordon W. Duncan, Tien K. Khoo, Lynn Rochester, Roger A. Barker, Rachael A. Lawson, John T. O’Brien, David J. Brooks, Shirley Coleman and Brook Galna.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact